Jill Kathleen Felts, OTR/L | |
15160 Foliage Ave Ste 170, Apple Valley, MN 55124-5916 | |
(952) 683-1745 | |
(952) 683-1746 |
Full Name | Jill Kathleen Felts |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 15160 Foliage Ave Ste 170, Apple Valley, Minnesota |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1184254823 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225XP0200X | Occupational Therapist - Pediatrics | 105813 (Minnesota) | Secondary |
225X00000X | Occupational Therapist | 105813 (Minnesota) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jill Kathleen Felts, OTR/L 15160 Foliage Ave Ste 170, Apple Valley, MN 55124-5916 Ph: (952) 683-1745 | Jill Kathleen Felts, OTR/L 15160 Foliage Ave Ste 170, Apple Valley, MN 55124-5916 Ph: (952) 683-1745 |
News Archive
The world's largest ever clinical trial looking at whether taking aspirin every day stops some of the most common cancers coming back, launches across the UK today (Thursday).
Immune Pharmaceuticals Inc., a clinical stage biopharmaceutical company that engages in the development and commercialization of targeted therapeutics for the treatment of inflammatory diseases and cancer, today completed the underwriter's exercise of partial over-allotment option of 459,697 units, at a price of $2.50 per unit, for gross proceeds of approximately $1.06 million, bringing the aggregate gross proceeds of the Company's previously announced underwritten public offering to $9.685 million.
Inovio Biomedical Corporation, a leader in DNA vaccine design, development and delivery, announced today additional interim safety and immunogenicity data from its therapeutic cervical cancer vaccine (VGX-3100) trial. VGX-3100 is a DNA vaccine targeting the E6 and E7 proteins of human papillomavirus (HPV) types 16 and 18 and is delivered via in vivo electroporation.
Caesarean section is one of the most common surgeries in the world, with rates continuing to rise, particularly in high- and middle-income countries.
Caraco Pharmaceutical Laboratories, Ltd. has started shipping bupropion hydrochloride extended release tablets. This product was recently approved by the US Food and Drug Administration (FDA) for Sun Pharma's Abbreviated New Drug Application (ANDA). These bupropion hydrochloride extended release tablets, 100 mg, 150 mg, and 200 mg, are therapeutically equivalent to GlaxoSmithKline's Wellbutrin SRĀ® Extended Release tablets.
› Verified 8 days ago
Elizabeth Ann Jeska, Occupational Therapist Medicare: Medicare Enrolled Practice Location: 14635 Pennock Ave Ste 300, Apple Valley, MN 55124 Phone: 651-994-9644 | |
Caitlin Mary Cooper, OTD, OTRL Occupational Therapist Medicare: Medicare Enrolled Practice Location: 15160 Foliage Ave Ste 170, Apple Valley, MN 55124 Phone: 952-683-1745 Fax: 952-683-1746 | |
Marisa Thomford, Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 14635 Pennock Ave Ste 300, Apple Valley, MN 55124 Phone: 651-994-9644 | |
Miss Jaclyn Ashley Hillstrom, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 14635 Pennock Ave, Suite 300, Apple Valley, MN 55124 Phone: 651-994-9644 Fax: 651-994-8962 | |
Mel P Homan, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 6400 131st Street Ct, Apple Valley, MN 55124 Phone: 612-423-3673 | |
Christine Spray, OTRL Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 14635 Pennock Ave, Suite 300, Apple Valley, MN 55124 Phone: 952-997-2823 Fax: 952-997-6931 |